In 2021, the American Society of Pharmacovigilance (ASP) launched the Fourth Cause Campaign to raise awareness that adverse drug events (ADEs) were the fourth leading cause of death in the United ...

The US pharmacovigilance market is expanding due to rising chronic diseases, stringent FDA regulations, and AI-driven ...

Tech Mahindra (NSE: TECHM), a leading global provider of technology consulting and digital solutions to enterprises across ...

Tech Mahindra and NVIDIA unveil an AI-powered pharmacovigilance solution to enhance drug safety, reducing delays, improving ...

The transformative solution leverages agentic artificial intelligence (AI) and automation to enhance the accuracy, speed, and efficiency of pharmacovigilance processes, addressing critical ...

Tech firms Wipro, TechMahindra, and L&T Technology partner with Nvidia to boost AI solutions. They unveil innovations like ...

In a move to enhance patient safety and strengthen pharmacovigilance, the All India Institute of Medical Sciences (AIIMS), ...

Tech Mahindra and NVIDIA have announced a collaboration to develop an autonomous pharmacovigilance solution for improving ...

Patients undergoing BRAF/MEK inhibitor therapy for melanoma more commonly experience VKH-like uveitis compared with other malignancy types.